Streetbeat News

Stock Prices

SMFL

Trading for SMFL was halted at 7:50:00 p.m. ET due to pending news. The halt is a temporary measure until the news affecting the company is released.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 11:50 pm

HEPA

Hepion Pharmaceuticals shares have resumed trading, indicating a return to market activity for the company.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 9:05 pm

AAPL

Sen. Elizabeth Warren criticized Apple Inc (NASDAQ:AAPL) for its smartphone market 'monopoly', particularly highlighting how the green text bubbles for non-iPhone users can ruin relationships and lead to social exclusion. Warren's comments support a Department of Justice antitrust case against Apple, focusing on the company's control over the smartphone market and its practices that lock users into its services. The DOJ's lawsuit includes claims of social stigmatization due to the blue vs. green text bubble issue, with Apple holding a 57% market share in North America as of January 2024.

Portfolio Pulse from Chris Katje

April 19, 2024 | 8:57 pm

HEPA

Trading for HEPA was halted and then resumed at 4:55:00 PM ET, with updates on quotation resumption, news, and resumption times provided.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:55 pm

COSM

Cosmos Health received a Nasdaq notice for the late filing of its Form 10-K. On April 17, the company was notified of non-compliance with Nasdaq Listing Rule 5250(c)(1). Cosmos Health intends to resolve this deficiency and regain compliance with Nasdaq listing rules, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:48 pm

NOW

Whales have shown a bearish stance on ServiceNow (NYSE:NOW), with options trading indicating a mix of bullish and bearish expectations. Notable trades include a range of puts and calls, targeting a price range from $300 to $1040. ServiceNow's current trading volume is 1,536,830, with a recent price drop of -2.39%, and an earnings announcement expected in 5 days.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 8:45 pm

AZN

AstraZeneca (NASDAQ:AZN) has seen significant bearish options activity, with 83% of traders showing bearish tendencies and a focus on a price band between $66.0 and $77.5. The largest options trades indicate a bearish sentiment despite a small portion of bullish activity. AstraZeneca, a major pharmaceutical company, has its stock slightly up by 0.28% at $68.55, with an upcoming earnings report in 6 days.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 8:45 pm

MNTS

Momentus Inc has received a deficiency notification from Nasdaq due to the delayed filing of its Form 10-K, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:42 pm

GURE

Gulf Resources, Inc. (GURE) received a Nasdaq non-compliance notice for not filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, on time. The company has until June 17, 2024, to file the report or submit a compliance plan to Nasdaq. If accepted, Nasdaq may grant up to October 14, 2024, for compliance. Failure to comply may result in delisting. Gulf Resources aims to file the report by June 10, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:41 pm

LFCR

Lifecore Biomedical, Inc. (LFCR) received a notice from Nasdaq on April 15, 2024, for not filing its quarterly reports for the periods ending February 25, 2024, August 27, 2023, and November 29, 2023, violating Nasdaq Listing Rule 5250(c)(1). Despite this, the company's stock remains listed as it appeals the potential delisting. Lifecore is working to complete and file the overdue reports to regain compliance.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 8:41 pm